ECE2015 Guided Posters Endocrine tumours and neoplasia – Adrenal Tumour (7 abstracts)
Mitotane inhibits sterol-o-acyltransferase leading to lipid-mediated endoplasmic reticulum stress and apoptosis of adrenocortical carcinoma cells
Silviu Sbiera 1, , Martin Fassnacht 1, , Ellen Leich 4 , Gerhard Liebisch 5 , Andreas Schirbel 6 , Laura Wiemer 1 , Silke Matysik 5 , Jens T Vanselow 7 , Felix Gardill 1 , Annemarie Gehl 1 , Sabine Kendl 1 , Melanie Beyer 1 , Margarita Bala 1 , Cristina L Ronchi 1 , Timo Deutschbein 1 , Andreas Schlosser 7 , Gerd Schmitz 6 , Andreas Rosenwald 2, , Bruno Allolio 1 & Matthias Kroiss 2
1Endocrinology and Diabetes Unit, University Hospital Würzburg, Würzburg, Germany; 2Comprehensive Cancer Center Mainfranken, Würzburg, Germany; 3Clinical Chemistry and Laboratory Medicine, University Hospital Würzburg, Würzburg, Germany; 4Institute of Pathology, University of Würzburg, Würzburg, Germany; 5Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany; 6Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany; 7Rudolf Virchow Center for Experimental Biomedicine, Würzburg, Germany.
Context: Mitotane is the only drug approved for treatment of adrenocortical carcinoma (ACC) and in clinical use for more than 50 years. Mitotane counteracts both tumour growth and tumoral steroid hormone production but treatment is associated with severe side effects. The molecular mechanism of mitotane is still unknown, which hampers progress in treatment of ACC.
Objective: To identify the mechanism of action and molecular target of mitotane.
Methods: We combined expression genomics, proteomics and lipidomics in an in vitro study using the NCI-H295 ACC reference cell line and four non-steroidogenic cell lines.
Results: Pathway analysis of gene expression data demonstrated activation of endoplasmic reticulum (ER) stress and altered lipid metabolism. Strongly increased expression of ER-stress marker C/EBP-homologous protein (CHOP, 26.7±0.1-fold, P<0.001) and activated XBP1-mRNA splicing (23.2±3.2-fold, P<0.001) was in sharp contrast to weak ER-stress activation in non-steroidogenic cell lines (HepG2: 2.6/1.4-fold, HEK293: 2.5/3.7, HeLa: 3.5/6.4, IMR-32: 1.5/2.1). ER-stress experimentally triggered by thapsigargin mimicked mitotane effects on steroidogenesis and apoptosis. Mass spectrometry revealed specific mitotane-induced lipid alterations with elevated free cholesterol (2.53-fold, P<0.05), oxysterols like 7-dehydrocholesterol (5.4-fold, P<0.001) and fatty acids, e.g. C20:4 (arachidonic acid; 3.2-fold, P<0.01) in NCI-H295 cells but not in other cell lines. Inhibition of Acyl-CoA-Cholesterol-Acyl-transferase (SOAT1) by mitotane (IC50=22 μM) was identified as the mechanism underlying these events.
Conclusions: Mitotane confers adrenal specific cytotoxicity and down-regulation of steroidogenesis by lipid-induced ER-stress through inhibition of SOAT-activity. This finding opens new avenues for improved ACC treatment. Cancer specific lipid metabolism may be a treatment target in other types of cancer.
Disclosure: This work was supported by Deutsche Forschungsgemeinschaft (grant FA 466/4-1 to M.F. and KR 4371/1-1 to M.K.), a fellowship of the Comprehensive Cancer Center Mainfranken to M.K., IZKF Würzburg (grant B-281 to M.F.), and the ERA-NET ‘E-Rare’.
Volume 37
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more